International Scientific Workshop On Integrative Medical Therapies

25/03/2026

Weekly tidbits on health and wellness

03/03/2026

17/11/2024

👨‍⚕️ Join us at the upcoming 6th International Congress of Integrative Medicine, where we're thrilled to introduce Dr. Homer Lim as a keynote speaker. Dr. Lim will be presenting on the compelling topic: "Repurposing Drugs for Cancer: The Philippine Experience."

This presentation will highlight the benefits and importance of repurposed drugs as well as in demonstrating efficacy in cancer treatment, addressing adverse events and the financial impact on patients medical care.

Don't miss this opportunity to gain insights from Dr. Lim's extensive experience and research. His talk promises to be a highlight of the congress, offering valuable perspectives on the future of cancer treatment and integrative medicine.

Stay tuned for more details and be sure to secure your spot for this enlightening session. Together, let's explore the future of integrative medicine and innovative cancer therapies!

🎟️ Tickets available for 6th International Congress of Integrative Medicine at https://icim.pt/

03/11/2024

05/04/2024

12/03/2024

Efrain Olszewer, MD A 72-year-old female patient, with arterial hypertension, consulted for an arterial ulcer in the right ankle (See photo 1, dated 3 March 2021). She had been treated conventionally for the last three months with no apparent results. Arterial ulcers are skin lesions caused by pro....

01/02/2024

& “Given the growth suppressive effect of the combination of atorvastatin and dipyridamole on PKCλ/ι-deficient cells (Fig. 7), we next investigated the therapeutic potential of this combination therapy on Prkcif/fPrkczf/f;Villin-Cre tumors in vivo (Fig. 8e). The complete absence of cleaved SREBP2 in the intestinal tissue (Fig. 8f) and the significant decrease in serum cholesterol levels (Fig. 8g) in these mice confirmed the efficacy of this treatment regimen in blocking cholesterol biosynthesis. Of potential therapeutic relevance, the combination treatment significantly reduced tumor number and load (Fig. 8h–j). This treatment also inhibited malignancy, as determined by a reduction in the percentage of cancer incidence (Fig. 8k) and a reduced number of SSLs and carcinomas (Fig. 8l). “

The underlying mechanisms driving colorectal cancer (CRC) through the serrated route are largely unknown. Here, the authors show that reduced aPKC levels increase cholesterol biosynthesis to promote aggressiveness in serrated tumours and targeting this pathway reduces tumourigenesis in preclinical m...